COVID‐19 effect on patients with noncommunicable diseases: A narrative review
<h3>Background and Aims</h3><p dir="ltr">On March 11, 2020, the WHO has declared COVID‐19 a global pandemic, affecting our day‐to‐day lives. Physical distancing and lockdown made significant obstacles to populations, particularly healthcare systems. Most healthcare worker...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | , , , , , , , , , , , |
| منشور في: |
2022
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| _version_ | 1864513547432624128 |
|---|---|
| author | Ahmad R. Al‐Qudimat (21348626) |
| author2 | Mohamed B. Al Darwish (21397997) Mai Elaarag (17807390) Raed M. Al‐Zoubi (21348629) Mohamed Amine Rejeb (21398000) Laxmi K. Ojha (21398003) Abdulqadir J. Nashwan (11659453) Timoor Alshunag (21398006) Karam Adawi (21398009) Abdelfettah El Omri (21398012) Omar M. Aboumarzouk (14779240) Aksam Yassin (14779204) Abdulla A. Al‐Ansari (21348638) |
| author2_role | author author author author author author author author author author author author |
| author_facet | Ahmad R. Al‐Qudimat (21348626) Mohamed B. Al Darwish (21397997) Mai Elaarag (17807390) Raed M. Al‐Zoubi (21348629) Mohamed Amine Rejeb (21398000) Laxmi K. Ojha (21398003) Abdulqadir J. Nashwan (11659453) Timoor Alshunag (21398006) Karam Adawi (21398009) Abdelfettah El Omri (21398012) Omar M. Aboumarzouk (14779240) Aksam Yassin (14779204) Abdulla A. Al‐Ansari (21348638) |
| author_role | author |
| dc.creator.none.fl_str_mv | Ahmad R. Al‐Qudimat (21348626) Mohamed B. Al Darwish (21397997) Mai Elaarag (17807390) Raed M. Al‐Zoubi (21348629) Mohamed Amine Rejeb (21398000) Laxmi K. Ojha (21398003) Abdulqadir J. Nashwan (11659453) Timoor Alshunag (21398006) Karam Adawi (21398009) Abdelfettah El Omri (21398012) Omar M. Aboumarzouk (14779240) Aksam Yassin (14779204) Abdulla A. Al‐Ansari (21348638) |
| dc.date.none.fl_str_mv | 2022-12-15T09:00:00Z |
| dc.identifier.none.fl_str_mv | 10.1002/hsr2.995 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/journal_contribution/COVID_19_effect_on_patients_with_noncommunicable_diseases_A_narrative_review/29116964 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Health sciences Epidemiology Health services and systems Public health COVID‐19 effectiveness epidemiology mortality noncommunicable disease prevalence |
| dc.title.none.fl_str_mv | COVID‐19 effect on patients with noncommunicable diseases: A narrative review |
| dc.type.none.fl_str_mv | Text Journal contribution info:eu-repo/semantics/publishedVersion text contribution to journal |
| description | <h3>Background and Aims</h3><p dir="ltr">On March 11, 2020, the WHO has declared COVID‐19 a global pandemic, affecting our day‐to‐day lives. Physical distancing and lockdown made significant obstacles to populations, particularly healthcare systems. Most healthcare workers were reallocated to COVID‐19 facilities. Noncommunicable disease patients were given low priority and are at a higher risk of severe COVID‐19 infection, which disrupted the treatment and disease management of these patients. This review aimed to assess the effect of COVID‐19 on different types of noncommunicable diseases and the severity it may cause to patients.</p><h3>Methods</h3><p dir="ltr">We have conducted a review of the literature on COVID‐19 and noncommunicable diseases from December 2019 until January 2022. The search was done in PubMed and Cochrane for relevant articles using variety of searching terms. Data for study variables were extracted. At the end of the selection process, 46 papers were selected for inclusion in the literature review.</p><h3>Result</h3><p dir="ltr">The result from this review found that the COVID‐19 pandemic has affected the efficiency of the patient's treatment indirectly by either delaying or canceling sessions, which solidified the need to rely more on telemedicine, virtual visits, and in‐home visits to improve patient education and minimize the risk of exposure to the patients. The major and most common types of noncommunicable diseases are known to be related to the severe outcomes of COVID‐19 infection. It is strongly recommended to prioritize these patients for vaccinations against COVID‐19 to provide them with the protection that will neutralize the risk imposed by their comorbidities.</p><h3>Conclusion</h3><p dir="ltr">We recommend conducting more studies with larger population samples to further understand the role of noncommunicable diseases (NCDs) in this pandemic. However, this pandemic has also affected the efficiency of NCDs treatment indirectly by delaying or canceling sessions and others.</p><h2>Other Information</h2><p dir="ltr">Published in: Health Science Reports<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1002/hsr2.995" target="_blank">https://dx.doi.org/10.1002/hsr2.995</a></p> |
| eu_rights_str_mv | openAccess |
| id | Manara2_bb017389a8186dd9db402e4e746fe906 |
| identifier_str_mv | 10.1002/hsr2.995 |
| network_acronym_str | Manara2 |
| network_name_str | Manara2 |
| oai_identifier_str | oai:figshare.com:article/29116964 |
| publishDate | 2022 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | COVID‐19 effect on patients with noncommunicable diseases: A narrative reviewAhmad R. Al‐Qudimat (21348626)Mohamed B. Al Darwish (21397997)Mai Elaarag (17807390)Raed M. Al‐Zoubi (21348629)Mohamed Amine Rejeb (21398000)Laxmi K. Ojha (21398003)Abdulqadir J. Nashwan (11659453)Timoor Alshunag (21398006)Karam Adawi (21398009)Abdelfettah El Omri (21398012)Omar M. Aboumarzouk (14779240)Aksam Yassin (14779204)Abdulla A. Al‐Ansari (21348638)Health sciencesEpidemiologyHealth services and systemsPublic healthCOVID‐19effectivenessepidemiologymortalitynoncommunicable diseaseprevalence<h3>Background and Aims</h3><p dir="ltr">On March 11, 2020, the WHO has declared COVID‐19 a global pandemic, affecting our day‐to‐day lives. Physical distancing and lockdown made significant obstacles to populations, particularly healthcare systems. Most healthcare workers were reallocated to COVID‐19 facilities. Noncommunicable disease patients were given low priority and are at a higher risk of severe COVID‐19 infection, which disrupted the treatment and disease management of these patients. This review aimed to assess the effect of COVID‐19 on different types of noncommunicable diseases and the severity it may cause to patients.</p><h3>Methods</h3><p dir="ltr">We have conducted a review of the literature on COVID‐19 and noncommunicable diseases from December 2019 until January 2022. The search was done in PubMed and Cochrane for relevant articles using variety of searching terms. Data for study variables were extracted. At the end of the selection process, 46 papers were selected for inclusion in the literature review.</p><h3>Result</h3><p dir="ltr">The result from this review found that the COVID‐19 pandemic has affected the efficiency of the patient's treatment indirectly by either delaying or canceling sessions, which solidified the need to rely more on telemedicine, virtual visits, and in‐home visits to improve patient education and minimize the risk of exposure to the patients. The major and most common types of noncommunicable diseases are known to be related to the severe outcomes of COVID‐19 infection. It is strongly recommended to prioritize these patients for vaccinations against COVID‐19 to provide them with the protection that will neutralize the risk imposed by their comorbidities.</p><h3>Conclusion</h3><p dir="ltr">We recommend conducting more studies with larger population samples to further understand the role of noncommunicable diseases (NCDs) in this pandemic. However, this pandemic has also affected the efficiency of NCDs treatment indirectly by delaying or canceling sessions and others.</p><h2>Other Information</h2><p dir="ltr">Published in: Health Science Reports<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1002/hsr2.995" target="_blank">https://dx.doi.org/10.1002/hsr2.995</a></p>2022-12-15T09:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1002/hsr2.995https://figshare.com/articles/journal_contribution/COVID_19_effect_on_patients_with_noncommunicable_diseases_A_narrative_review/29116964CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/291169642022-12-15T09:00:00Z |
| spellingShingle | COVID‐19 effect on patients with noncommunicable diseases: A narrative review Ahmad R. Al‐Qudimat (21348626) Health sciences Epidemiology Health services and systems Public health COVID‐19 effectiveness epidemiology mortality noncommunicable disease prevalence |
| status_str | publishedVersion |
| title | COVID‐19 effect on patients with noncommunicable diseases: A narrative review |
| title_full | COVID‐19 effect on patients with noncommunicable diseases: A narrative review |
| title_fullStr | COVID‐19 effect on patients with noncommunicable diseases: A narrative review |
| title_full_unstemmed | COVID‐19 effect on patients with noncommunicable diseases: A narrative review |
| title_short | COVID‐19 effect on patients with noncommunicable diseases: A narrative review |
| title_sort | COVID‐19 effect on patients with noncommunicable diseases: A narrative review |
| topic | Health sciences Epidemiology Health services and systems Public health COVID‐19 effectiveness epidemiology mortality noncommunicable disease prevalence |